Gut Health

After H. Pylori Treatment: What Actually Happens to Your Gut and How to Support Recovery

Eradicating H. pylori is genuinely important. It removes a bacterium that damages the stomach lining, causes ulcers, and increases the risk of gastric cancer. But eradication is not the end of the story. The treatment that clears the infection leaves the gut in a state that needs active support, and most people are sent home with no guidance on that next step.

Faizel Patel

Founder, Gut Axis

June 2026
11 min read

44% Of the global population estimated to carry H. pylori, making it one of the most common chronic bacterial infections

3 drugs Standard UK eradication triple therapy: two antibiotics plus a proton pump inhibitor taken together

8 weeks Minimum time the NHS recommends before retesting after eradication treatment is completed

What H. pylori actually does to the stomach lining

Helicobacter pylori is a bacterium that has evolved specifically to survive in the hostile acidic environment of the stomach. It does this by producing an enzyme called urease, which converts urea to ammonia and carbon dioxide, creating a localised alkaline microenvironment that neutralises acid around the bacterium. This allows it to embed into the mucus layer of the stomach lining and persist indefinitely without treatment.

The damage H. pylori causes to the stomach lining is not simply from its presence. It is from the inflammatory response it triggers and from the specific virulence factors it produces. The CagA protein, carried by the most virulent strains, is injected directly into the cells of the stomach lining and disrupts their normal function. The VacA toxin damages the tight junctions between gastric epithelial cells and causes cell death. The urease enzyme itself is inflammatory to mucosal tissue at sustained concentrations.

The cumulative effect is a stomach lining that is chronically inflamed, structurally compromised, and producing less of the protective mucus that the stomach wall depends on. This is the foundation of H. pylori-associated gastritis, and it is why the symptoms of H. pylori infection look and feel so similar to gastritis that has developed from other causes: the underlying mechanism at the mucosal level is essentially the same.

Research context

A 2025 systematic review in Frontiers in Cellular and Infection Microbiology confirmed that H. pylori infection produces "significant alterations in gut and gastric microbiota, with a notable increase in inflammation-associated bacteria such as Proteobacteria and Streptococcus," and that eradication therapies themselves "impact microbial balance" in ways that create an additional layer of disruption on top of the damage caused by the infection itself. View source →

What eradication treatment involves and what it does to the gut

The standard UK eradication treatment for H. pylori is triple therapy: a seven-day course of a proton pump inhibitor taken alongside two different antibiotics, most commonly clarithromycin and amoxicillin, or metronidazole where amoxicillin is not suitable. Some cases require quadruple therapy with four agents including bismuth. The NHS advises retesting at a minimum of four weeks, ideally eight weeks, after completing the course to confirm eradication.

The treatment is effective. Eradication rates in the UK range from roughly 70 to 90 per cent depending on the regimen and local antibiotic resistance patterns. For most people, successfully completing the course clears the infection. What it does not do is address the state the stomach lining and gut microbiome are left in after both the infection and the treatment.

What the antibiotics do to the gut

Two broad spectrum antibiotics simultaneously

Clarithromycin and amoxicillin are both broad-spectrum antibiotics. They do not selectively target H. pylori. They reduce bacterial populations throughout the gastrointestinal tract, including the beneficial bacteria in the gut microbiome that produce butyrate, maintain barrier integrity, and regulate immune function. Taking two antibiotics simultaneously for seven days creates more extensive microbiome disruption than a single antibiotic course.

Research has found that gut microbiome diversity is significantly reduced immediately after H. pylori eradication therapy, with some beneficial species remaining depleted for weeks to months after treatment ends. Butyrate-producing species, particularly those from the Lachnospiraceae and Ruminococcaceae families, are among those most affected and among the slowest to recover without active support.

What the PPI does

Acid suppression on top of microbiome disruption

The proton pump inhibitor in the triple therapy regimen reduces acid production to allow the antibiotics to work more effectively in the gastric environment. But as we have covered in detail elsewhere on this site, PPIs have their own effects on the gut microbiome. They reduce the acid gatekeeping that prevents oral bacteria from reaching the gut, allowing bacteria that would ordinarily be neutralised in the stomach to colonise the lower gastrointestinal tract. Combined with the direct antibiotic disruption, the triple therapy creates a significant compound effect on gut microbial ecology.

Many people continue the PPI after completing the antibiotic component, either as prescribed for ulcer healing or independently because the acid-related symptoms have not fully resolved. Every additional week of PPI use extends the period of altered gastric acid environment and its knock-on effects on the microbiome.

Why symptoms often persist after successful eradication

This is the question that brings most people to this article. The test confirms the infection has cleared. The antibiotics are finished. And yet the stomach still feels wrong. Bloating that was not there before. A digestive system that feels more sensitive rather than less. Foods that now cause problems. A stomach that has not returned to how it felt before the infection.

There are several overlapping reasons this is common, and none of them mean the treatment failed or that something more serious is wrong.

"Eradication clears the infection. It does not repair the mucosal lining that years of H. pylori damage left compromised. That step requires something different."

First, the mucosal lining of the stomach has been under inflammatory attack, potentially for years. H. pylori infections are typically longstanding before they are detected. The mucosal damage accumulated over that period does not reverse simply because the causative bacterium has been removed. The lining needs active conditions for repair and those conditions do not automatically exist after eradication.

Second, the antibiotic treatment has significantly disrupted the gut microbiome. The butyrate-producing bacteria that fuel the cells of the gut lining are depleted. The cells are now attempting to renew and repair in an environment with reduced fuel supply and altered microbial signalling. Recovery under these conditions is slower than recovery with a healthy, diverse microbiome providing full support.

Third, in some people the H. pylori-associated gastritis has progressed beyond superficial mucosal inflammation to atrophic changes in the stomach lining, where the mucus-producing cells have been significantly reduced. These more established structural changes take longer to stabilise and may require more sustained support.

The three things that need recovery after H. pylori treatment

The gastric mucosal lining

The stomach lining has been under direct attack from H. pylori virulence factors for however long the infection was present. The mucosal cells that produce the protective mucus layer have been damaged and in some cases reduced in number. Eradicating the bacterium removes the source of ongoing damage but the existing structural compromise remains. The mucosal cells need specific nutritional support for repair, and the conditions that favour their regeneration need to be actively created rather than assumed.

The gut microbiome

A 2025 systematic review confirmed that eradication therapies consistently alter gut microbial balance. The impact is on top of whatever disruption the H. pylori infection itself had already caused to the gastric microbiome over the course of the infection. What is left post-treatment is a significantly altered microbial ecosystem that needs active dietary and probiotic support to rebuild the diversity and the specific functional populations that gut lining health depends on.

Research using bismuth-based quadruple therapy found that the transient perturbation of gut microbiota after H. pylori eradication was not fully recovered in subjects receiving this regimen even after extended follow-up, in contrast to subjects receiving simpler regimens where partial recovery occurred at eight weeks. The type of eradication regimen matters for how much microbiome support is needed afterwards.

The broader intestinal barrier

H. pylori's effects are not confined to the stomach. The systemic inflammation associated with chronic H. pylori infection, and the microbiome changes it produces, have downstream effects on intestinal permeability throughout the gastrointestinal tract. The tight junction proteins that maintain gut barrier integrity are affected by the inflammatory environment that H. pylori sustains. Recovery of the broader gut barrier, not just the stomach lining specifically, is part of the full picture of post-eradication recovery.

The realistic recovery timeline

Week 1 to 2 after treatment ends

Acute antibiotic aftermath

Gut microbiome disruption is at its most significant in this window. Diarrhoea, bloating, and unusual digestive patterns are common and are largely a consequence of the antibiotic effect on the gut microbiome rather than a sign the treatment failed. This is the period where probiotic support and dietary fibre matter most.

Weeks 3 to 8

Initial microbiome reseeding

Most beneficial bacterial populations begin to return. The NHS recommends retesting at a minimum of four weeks and ideally eight weeks post-treatment. Some people notice digestive improvement settling in during this window. Others continue to experience bloating and food sensitivity as the microbiome and mucosal lining are still in the recovery process.

Months 2 to 4

Mucosal repair and microbiome stabilisation

With active dietary and nutritional support, meaningful mucosal repair becomes established during this period. The gastric lining cells, which turn over every few days, have had multiple renewal cycles by now. The quality of that renewal depends heavily on the nutritional environment provided during this window. Microbiome diversity begins approaching a more stable state with consistent prebiotic and probiotic support.

Months 4 to 6

Baseline stabilisation

For most people with straightforward H. pylori-associated gastritis without significant atrophic changes, this is when the gut begins to feel genuinely stable rather than recovering. Food tolerances improve. Bloating reduces. The stomach feels more predictable. For those with more established mucosal damage, meaningful recovery can take longer and benefit from sustained support beyond this point.

Beyond 6 months

Long-term maintenance

Once mucosal and microbiome recovery is established, the goal shifts to maintaining the conditions that prevent recurrence and support long-term gut resilience. Diet diversity, stress management, avoiding unnecessary NSAID use, and ongoing prebiotic and probiotic support are the pillars of this phase.

What commonly supports recovery after H. pylori treatment

The following approaches are those with the most consistent research support specifically in the context of post-H. pylori recovery. They address the three distinct areas of recovery identified above: the mucosal lining, the microbiome, and the broader gut barrier.

DGL (Deglycyrrhizinated Licorice)

One of the most specifically relevant botanicals for gastric mucosal recovery after H. pylori. DGL stimulates mucus-producing cells, increases blood flow to the gastric mucosa, and has documented inhibitory activity against H. pylori itself in in-vitro studies. The deglycyrrhizinated form is suitable for long-term daily use.

L-Glutamine

The primary fuel for gastric and intestinal epithelial cells. Supports mucosal cell renewal and tight junction integrity throughout the gastrointestinal tract. At a dose of 5g per serving it provides meaningful support for the mucosal repair process that H. pylori treatment leaves incomplete.

Bacillus Coagulans

A spore-forming probiotic strain with strong stability and resilience through the digestive process. Research has specifically examined probiotic use in H. pylori eradication contexts, with probiotics shown to help restore gastric and gut dysbiosis after treatment, particularly depletion of beneficial Faecalibacterium prausnitzii populations.

Marshmallow Root

Provides a physical mucilage coating over the irritated gastric mucosa while the underlying mucosal cells repair. Particularly relevant in the first weeks after treatment when the stomach lining is most exposed and reactive.

Zinc Bisglycinate

Zinc deficiency is associated with impaired mucosal healing and increased susceptibility to gastric damage. Bisglycinate is a highly bioavailable form that supports the cellular repair of the gastric lining. Relevant both during the mucosal recovery phase and as an ongoing supportive nutrient.

Aloe Vera Gel

Supports healthy mucus production and has anti-inflammatory properties at the mucosal level. Inner leaf aloe vera in appropriate quantities provides soothing support to the gastric mucosa during the recovery period when irritation and sensitivity are typically highest.

Research context

Research has found that probiotics used alongside or after H. pylori eradication therapy help restore gastric dysbiosis, "especially gut F. prausnitzii depletion," with some studies suggesting probiotics may improve eradication rates when used adjunctively with antibiotic therapy. The 2025 systematic review confirmed that eradication therapies produce consistent microbial disruption that probiotic and dietary intervention can meaningfully address. View source →

Dietary approaches for the recovery period

Diet plays a specific and documented role in both gastric mucosal recovery and microbiome reseeding after H. pylori treatment. The following approaches are those most consistently supported by the research relevant to this specific recovery context.

Prebiotic fibre diversity is the most important dietary priority for restoring the butyrate-producing microbiome populations depleted by the dual antibiotic course. Garlic, onions, leeks, oats, asparagus, and bananas are among the best sources. Building intake gradually avoids triggering excessive bloating in an already sensitive post-treatment gut.
Fermented foods introduce beneficial bacterial strains directly. Live yoghurt, kefir, kimchi, and sauerkraut provide microbial diversity that supports the reseeding process. Choosing products with live and active cultures rather than heat-treated versions is important for this purpose.
Soft, easily digested foods in the first two to four weeks reduce the mechanical and digestive burden on a stomach lining that is still inflamed and healing. Soups, cooked vegetables, porridge, and easily digestible proteins reduce the immune activation that comes from processing harder-to-digest foods while the mucosal barrier is compromised.
Polyphenol-rich foods including berries, green tea, olive oil, and broccoli have anti-inflammatory properties at the mucosal level and support tight junction protein expression. They are among the most well-researched dietary components for intestinal barrier support.
Adequate protein provides the amino acid substrates, particularly glutamine, glycine, and proline, that the gastric mucosal cells use for repair and renewal. Bone broth, fish, eggs, and legumes are all relevant protein sources during the recovery period.

Alcohol is directly toxic to the gastric mucosal cells that are actively trying to repair. Avoiding alcohol entirely during the first four to six weeks after treatment and keeping it minimal beyond that gives the mucosal recovery the best possible conditions.
NSAIDs including ibuprofen and aspirin directly damage the gastric mucosal layer through prostaglandin inhibition. Using them during the post-eradication recovery period significantly compromises mucosal repair. Paracetamol is a safer alternative for pain management during this window.
Coffee and very spicy foods are both direct irritants to a stomach lining that is already inflamed. Neither needs to be eliminated permanently, but reducing them during the acute recovery phase reduces the daily irritation load on a mucosa that is trying to repair.

Frequently asked questions

How do I know if my H. pylori eradication was successful?

The NHS recommends retesting at a minimum of four weeks after completing treatment, and ideally at eight weeks. The standard retesting method is a breath test or stool antigen test. Blood tests are not used for confirmation of eradication because antibodies can remain in the blood for months after the infection has cleared and will show a false positive. It is important to stop any proton pump inhibitors at least two weeks before retesting, as PPIs can suppress H. pylori below detectable levels without actually clearing the infection, producing a false negative result.

Can H. pylori come back after successful eradication?

Reinfection after successful eradication does occur but is uncommon in the UK, where sanitation standards are high and the primary transmission routes are controlled. Studies in high-income countries report reinfection rates of around one to two per cent per year. In practice, confirmed reinfection after eradication in the UK context is relatively rare. If symptoms return after confirmed successful eradication, they are more likely related to the mucosal damage and dysbiosis left behind by the infection and treatment than to reinfection, which is why active recovery support matters.

Can supplements be taken during H. pylori eradication treatment?

Taking supplements during the antibiotic course itself requires specific consideration. Probiotics taken during an antibiotic course should be spaced at least two hours from each antibiotic dose to reduce the likelihood of the antibiotic eliminating them before they can colonise. L-Glutamine, Marshmallow Root, and DGL are not known to interact with the standard H. pylori treatment antibiotics but you should always confirm with your GP or pharmacist before taking any supplements alongside prescribed medication. Some research suggests that probiotics used as an adjunct to H. pylori therapy may actually improve eradication rates while reducing antibiotic side effects.

Why do I feel worse after finishing the H. pylori treatment than I did before?

This is a very common experience and it has a straightforward explanation. The antibiotics have significantly disrupted the gut microbiome, depleting the beneficial bacteria that support digestion, gut lining integrity, and immune regulation. The stomach lining, while no longer under active H. pylori attack, has been chronically inflamed and is now trying to repair in a microbiome environment that has been significantly altered. The gut is often more sensitive and reactive in the weeks immediately after treatment than it was during the infection, precisely because the protective microbial and mucosal environment has been disrupted. This is the period where active recovery support makes the most meaningful difference.

How long should I take gut lining supplements after H. pylori treatment?

There is no fixed protocol that applies universally. The research and clinical experience suggest that a minimum of three to six months of consistent gut lining and microbiome support gives the mucosal repair process adequate time to establish meaningful progress. For people who had significant mucosal damage before treatment, or who have been on PPIs long term alongside the H. pylori infection, longer sustained support is likely more appropriate. The most practical guide is your own symptom trajectory: if bloating, food reactivity, and digestive sensitivity are still meaningfully present at three months, continuing support through to six months is reasonable.

Back to blog